Multicenter study of the BCG Tokyo strain for intravesical treatment in patients with superficial bladder cancer. BCG Study Group.
Aso
Y
Y
Department of Urology, Faculty of Medicine, University of Tokyo, Japan.
Akaza
H
H
Kameyama
S
S
Niijima
T
T
D000283:Administration, Intravesical; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002278:Carcinoma in Situ / Q000628:therapy; D002291:Carcinoma, Papillary / Q000628:therapy; D005260:Female; D006801:Humans; D007322:Instillation, Drug; D007564:Japan; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
D001500:BCG Vaccine